Oliver Lagore Vanvalin Investment Group Novartis Ag Transaction History
Oliver Lagore Vanvalin Investment Group
- $359 Million
- Q3 2024
A detailed history of Oliver Lagore Vanvalin Investment Group transactions in Novartis Ag stock. As of the latest transaction made, Oliver Lagore Vanvalin Investment Group holds 200 shares of NVS stock, worth $19,994. This represents 0.01% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$19,994
Previous $21,000
9.52%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding NVS
# of Institutions
1,423Shares Held
130MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.22 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.2 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$809 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$698 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$577 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $215B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...